CARR'S GROUP PLC

Regulatory Filings • Dec 19, 2025

National Storage Mechanism | Additional information

RNS Number : 3528M

Fevara PLC

19 December 2025

19 December 2025

Fevara plc

("Fevara", the "Company", or the "Group")

Notice of 2026 AGM and Publication of Annual Report and Accounts for FY25

Notice of 2026 AGM

Fevara plc (LSE: FVA), an international specialist in livestock supplements, announces that its 2026 Annual General Meeting ("AGM") will be held at 1.00pm GMT on Wednesday 11 February 2026 at The Halston Hotel Carlisle, 20-34 Warwick Road, Carlisle CA1 1AB in The Mail Exchange function room.

The Notice of Meeting for the 2026 AGM and a Form of Proxy for use at the 2026 AGM are available to view on the Company's website at  https://fevara.com/investors/shareholder-meetings/.

Annual Report and Accounts for FY25

The Company's Annual Report and Accounts for the year ended 31 August 2025 (the "Annual Report and Accounts for FY25") has been published on the Company's website at https://fevara.com/investors/results-centre/  and submitted to the Financial Conduct Authority. It will shortly be available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism/.

Hard copies of the Annual Report and Accounts for FY25, together with the Notice of 2026 AGM and any other ancillary documents in respect of the 2026 AGM, have been posted to shareholders who have elected to receive paper communications.

Enquiries:

Fevara plc Paula Robertson (Company Secretary)	+ 44 (0)1228 554 600

About Fevara plc:

Fevara is an international specialist in livestock supplements.

Fevara's purpose is to empower farmers in extensive grazing systems with research-proven products that boost profitability, improve resource efficiency and support sustainable agriculture.  The Group develops, manufactures and markets research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep and horses, sold under recognised and trusted brands, including Crystalyx®, HorsLic®, Horslyx®, Scotmin Nutrition®, SmartLic® and Tracesure® Advanced.

Headquartered in Carlisle, Cumbria, in the UK, Fevara has four manufacturing sites in the UK and the US, with three operational joint ventures in Germany and the US. It serves customers in more than 20 countries through its expansive international distribution and support network.

Fevara has been listed on the London Stock Exchange since 1972.

For more information, visit: www.fevara.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAMZMMZVLKGKZM